CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 

X4 Pharmaceuticals Inc's Tangible Leverage Ratio

XFOR's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


In I Quarter 2024 X4 Pharmaceuticals Inc had stockholder deficit.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2024, 70 other companies have achieved lower Tangible Leverage Ratio than X4 Pharmaceuticals Inc in the I Quarter 2024. While Tangible Leverage Ratio total ranking has deteriorated compared to the third quarter 2023 from 2410 to 2918 .

Explain Tangible Leverage Ratio?
What is XFOR Market Share?
What are XFOR´s Total Liabilities?


XFOR Tangible Leverage Ratio (Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Tangible Equity Change - 12.91 % 294.47 % 6.06 % 20.48 %
Y / Y Total Liabilities Change 36.94 % 107.53 % 110.23 % 46.62 % 55.42 %
Tangible Leverage Ratio MRQ - 2.08 2.09 2.08 1.42
XFOR's Total Ranking # 2918 # 2410 # 1726 # 2170 #
Seq. Tangible Equity Change - 0.12 % 46.2 % -39.46 % 27.42 %
Seq. Total Liabilities Change 5.19 % -0.13 % 46.35 % -10.93 % 59.42 %



Tangible Leverage Ratio first quarter 2024 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 71
Healthcare Sector # 536
Overall Market # 2918


Tangible Leverage Ratio Statistics
High Average Low
106.19 5.16 0.24
(Mar 31 2024)   (Dec 31 2019)




Financial Statements
X4 Pharmaceuticals Inc's Tangible Equity $ -16 Millions Visit XFOR's Balance sheet
X4 Pharmaceuticals Inc's Total Liabilities $ 110 Millions Visit XFOR's Balance sheet
Source of XFOR's Sales Visit XFOR's Sales by Geography


Cumulative X4 Pharmaceuticals Inc's Tangible Leverage Ratio

XFOR's Tangible Leverage Ratio for the trailling 12 Months

XFOR Tangible Leverage Ratio

(Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Tangible Equity TTM Growth - 12.91 % 294.47 % 6.06 % 20.48 %
Y / Y Total Liabilities TTM Growth 36.94 % 107.53 % 110.23 % 46.62 % 55.42 %
Tangible Leverage Ratio TTM 3.3 1.89 1.65 1.7 1.57
Total Ranking TTM
Seq. Tangible Equity TTM Growth - 0.12 % 46.2 % -39.46 % 27.42 %
Seq. Total Liabilities TTM Growth 5.19 % -0.13 % 46.35 % -10.93 % 59.42 %


On the trailing twelve months basis During the 12 months period ending I Quarter 2024 company had stockholder deficit.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry 63, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than X4 Pharmaceuticals Inc. While Tangible Leverage Ratio total ranking has deteriorated during the twelve months ending in the I Quarter 2024, compared to the prior period, from 7 to 2629.

Explain Tangible Leverage Ratio?
What is XFOR Market Share?
What are XFOR´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 64
Healthcare Sector # 477
Within the Market # 2918


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
2.11 0.77 0.31
(Mar 31 2024)   (Jun 30 2020)




Companies with similar Tangible Leverage Ratio in the quarter ending Mar 31 2024, within Biotechnology & Pharmaceuticals Industry Tangible Leverage RatioMar 31 2024 MRQ Total LiabilitiesMar 31 2024 MRQ Tangible Equity

Date modified: 2024-05-08T15:34:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com